Recommended
Recommended
More Related Content
What's hot
What's hot (19)
Viewers also liked
Viewers also liked (6)
Similar to Me Ta Private Sector Meeting 23 June 2009
Similar to Me Ta Private Sector Meeting 23 June 2009 (20)
More from MeTApresents
More from MeTApresents (20)
Recently uploaded
Recently uploaded (20)
Me Ta Private Sector Meeting 23 June 2009
- 1. MeTA Consultative Meeting with Pharmaceutical Industry A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 2. Financial Times Welcome and Introduction Andrew Jack 23/06/09
- 3. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 4. Growth and Investment Group, DFID Opening remarks Calum Miller 23/06/09
- 5. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 6. International MeTA Secretariat Brian Elliott 23/06/09
- 7. Brian Elliott, Executive Director, International MeTA Secretariat CONSULTATIVE MEETING WITH THE PHARMACEUTICAL INDUSTRY 23 June 2009, London Medicines Transparency Alliance(MeTA) Creating a level playing field in emerging markets
- 18. MeTA 23/06/09
- 25. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 26. In Country MeTA – How MeTA works in four pilot countries 23/06/09
- 27. Pharmaceutical and Healthcare Association of the Philippines Reiner W. Gloor MeTA 23/06/09
- 36. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 37. Pharmaceutical Manufacturers Association of Ghana (PMAG) Paul Lartey MeTA 23/06/09
- 51. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 52. Uganda Pharmaceutical Manufacturers Association Nazeem Mohamed MeTA 23/06/09
- 66. Private Sector & MeTA Private Sector Needs MeTA Projects Lack of Data Addressing (pricing/NDA) Insufficient Skills Not addressed Poor Patient Information Addressing (HEPS/PSU) Poor Distribution Partly addressed (MoH) Unfair Competition Not addressed
- 68. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 69. Jordanian Association of Manufacturers of Pharmaceuticals and Medical Appliances Hanan Sboul MeTA 23/06/09
- 74. Stakeholders in MeTA Council WHO DFID WB
- 79. Committee I
- 80. Committee II
- 81. Committee III
- 85. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 86. Epirus Oriol Ramis MeTA 23/06/09
- 94. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 95. Plenary group feedback discussions MeTA 23/06/09
- 96. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 97. Peter Stephens, IMS HEALTH Wilbert Bannenberg, Technical Director, MeTA Transparency, data and information to be disclosed in MeTA pilot countries MeTA 23/06/2009
- 109. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 110. International MeTA Secretariat Andrew Chetley MeTA 23/06/09
- 111. Andrew Chetley Communication and Capacity Strengthening Director International MeTA Secretariat 23 June 2009, Consultative meeting with the pharmaceutical industry, London Medicines Transparency Alliance (MeTA): The core principles MeTA 16/09/2008
- 119. Will poor people in these countries have greater access to medicines? 16/09/2008 MeTA
- 121. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 122. Indian Pharmaceutical Alliance Dilip Shah MeTA 23/06/09
- 123. London 23 June 2009 By D G Shah Secretary General Indian Pharmaceutical Alliance Industry Engaging with the MeTA Concept and Principles
- 125. Global Experience IPA: 06/09 Prices of ARV Triple Combination : 2000-2003 Source: Sources and Prices of Medicines June 2003, A Joint Unicef, UNAIDS, WHO, MSF Project Prices Per Patent Per Year Originator $ $727 Originator $ 10439 Brazil $2767 Hetero $347 Ranbaxy $295 Aurobindo $209 Hetero $201 Cipla $350 Originator $ $ 931
- 132. THANK YOU [email_address] IPA: 06/09
- 133. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 134. Panel discussion and industry feedback MeTA 23/06/09
- 135. Andrew Jack – Financial Times Chair MeTA 23/06/09
- 136. Panel MeTA 23/06/09
- 137. MeTA International Advisory Group Sophia Tickell MeTA 23/06/09
- 138. Indian Pharmaceutical Alliance Dilip Shah MeTA 23/06/09
- 139. American Pharmaceutical Group Workstream Chris Mockler MeTA 23/06/09
- 140. European Generics Medicines Association Rory O’Riordan MeTA 23/06/09
- 141. A LEVEL PLAYING FIELD IN EMERGING MARKETS: IMPROVING ACCESS TO MEDICINES 23 June 2009 23/06/09
- 142. Andrew Jack Summary and Conclusions MeTA 23/06/09
- 143. Thank You ! 23/06/09
Editor's Notes
- Title of presentation 23/06/09 MeTA
- Support to countries through the MeTA International Secretariat, funds from DFID to support country work, and, upon request, technical assistance. Title of presentation 23/06/09 MeTA
- This scenario would provide the basis for fair and open competition among ethical pharmaceutical companies and other private sector groups involved in the supply of pharmaceuticals. Increasing access to medicines implies increasing market size with higher volume sales and profits for manufacturers, distributors and retailers Access to accurate market information will enable companies to develop cohesive marketing and sales strategies and plans, and to identify opportunities and openings in the market. Title of presentation 23/06/09 MeTA
- MeTA is committed to the creation of this level playing field in 7 pilot countries, - Jordan, Ghana, Peru, Kyrgyzstan, Zambia, The Philippines and Uganda Later in further countries should the process be deemed to be successful in an evaluation of in these pilots which will take place in the first quarter of next year Title of presentation 23/06/09 MeTA
- MeTA has been in existence for one year MeTA process is now in full operation all 7 pilot countries Further countries have expressed interest in the MeTA concept Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA MeTA developing these tools with Harvard, WB, WHO and others
- Country contexts are varied. varied and sometimes conflicting interests – need to be worked thorugh Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA For more information, visit the website, engage in the international discussion forum
- Following the MeTA forum in January, 25 CSOs grouped together and nominated one person to represent them in the MeTA council
- While MeTA conducted meetings among various sectors before the IRR was published, there was no more engagement of MeTA after that.
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA
- Title of presentation 23/06/09 MeTA